- Home
- ARL vs AVIR Comparison
ARL vs AVIR Comparison
Compare ARL & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- AVIR
- Stock Information
- Founded
- ARL 1999
- AVIR 2012
- Country
- ARL United States
- AVIR United States
- Employees
- ARL N/A
- AVIR N/A
- Industry
- ARL Building operators
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- ARL Real Estate
- AVIR Health Care
- Exchange
- ARL Nasdaq
- AVIR Nasdaq
- Market Cap
- ARL 231.0M
- AVIR 247.5M
- IPO Year
- ARL N/A
- AVIR 2020
- Fundamental
- Price
- ARL $15.70
- AVIR $3.29
- Analyst Decision
- ARL
- AVIR Hold
- Analyst Count
- ARL 0
- AVIR 1
- Target Price
- ARL N/A
- AVIR $6.88
- AVG Volume (30 Days)
- ARL 7.0K
- AVIR 491.5K
- Earning Date
- ARL 11-07-2024
- AVIR 11-07-2024
- Dividend Yield
- ARL N/A
- AVIR N/A
- EPS Growth
- ARL N/A
- AVIR N/A
- EPS
- ARL N/A
- AVIR N/A
- Revenue
- ARL $51,029,000.00
- AVIR N/A
- Revenue This Year
- ARL N/A
- AVIR N/A
- Revenue Next Year
- ARL N/A
- AVIR N/A
- P/E Ratio
- ARL N/A
- AVIR N/A
- Revenue Growth
- ARL 0.87
- AVIR N/A
- 52 Week Low
- ARL $12.51
- AVIR $2.75
- 52 Week High
- ARL $25.96
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- ARL 44.54
- AVIR 49.07
- Support Level
- ARL $13.96
- AVIR $3.10
- Resistance Level
- ARL $15.67
- AVIR $3.27
- Average True Range (ATR)
- ARL 0.92
- AVIR 0.16
- MACD
- ARL -0.27
- AVIR 0.02
- Stochastic Oscillator
- ARL 27.97
- AVIR 55.28
About ARL American Realty Investors Inc.
American Realty Investors Inc is a real estate company. The company acquires, develops, and owns income-producing residential and commercial real estate properties. Its segment involves the Residential segment and the Commercial segment. The residential segment is engaged in the acquisition, development, ownership, and management of multifamily properties and the Commercial segment is engaged in the acquisition, ownership, and management of commercial real estate properties. Its holdings include apartments, office buildings, retail centers, and parcels of land.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).